Decreased total serum adiponectin and its isoforms in women with acute ischemic stroke

Neuroendocrinology Letters

Volumn 32, Issue 5, 2011, Pages 711-715

  Baranowska, Boguslawa ^a   Kochanowski, Jan ^b   Grudniak, Mariusz ^b   Baranowska Bik, Agnieszka ^a   Wolinska Witort, Ewa ^a   Martynska, Lidia ^a   Bik, Wojciech ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Acute ischemic stroke; Adiponectin; Adiponectin isoforms

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH MOLECULAR WEIGHT ADIPONECTIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW MOLECULAR WEIGHT ADIPONECTIN; MIDDLE MOLECULAR WEIGHT ADIPONECTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 84857431583     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Atzmon G, Pollin TI, Crandall J, Tanner K, Schechter CB, Scherer PE, ef al. (2008). Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci. 63: 447-453.
2. Basu R, Pajvani UB, Rizza RA, Scherer PE, (2007). Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes. 56: 2174-2177. (Pubitemid 47195840)
3. Bik W, Baranowska-Bik A, Wolinska-Witort E, Martynska L, Chmielowska M, Szybinska A, et al. (2006). The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuro Endocrinol Lett. 27: 493-500. (Pubitemid 46043607)
4. Chen B, Liao WQ, Xu N, Xu H, Wen JY, Yu CA, et al. (2009). Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res. 1273: 129-137.
5. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. (2003). Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 278: 45021-45026. (Pubitemid 37377262)
6. Dekker JM, Funahashi T, Nijpels G, Pilz S, Stehouwer CD, Snijder MB, et al. (2008). Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab. 93: 1489-1496. (Pubitemid 351519753)
7. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD (2005). Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke. 36: 1915-1919. (Pubitemid 41266526)
8. Goldstein LB, Adams R, Alberts MJ, Appel U, Brass LM, Bushnell CD, ef al. (2006). American Heart Association/American Stroke Association Stroke Council; Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; Quality of Care and Outcomes Research Interdisciplinary Working Group; American Academy of Neurology. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke. 37: 1583-1633.
9. Goldstein BJ, Scalia RG, Ma XL (2009). Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med. 6: 27-35.
10. Hegener HH, Lee IM, Cook NR, Ridker PM, Zee RY (2006). Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. Clin Chem. 52: 2021-2027. (Pubitemid 44658202)
11. Kadowaki T, Yamauchi T, Kubota N (2008). The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett. 582: 74-80. (Pubitemid 50012818)
12. Marousi S, Theodorou G, Karakantza M, Papathanasopoulos P, Ellul J (2010). Serum adiponectin acutely after an ischemic stroke: implications for a long-lasting, suppressed anti-inflammatory role. Acta Neurol Scand. 121: 277-284.
13. Marousi SG, Theodorou GL, Karakantza M, Zampakis P, Papathanasopoulos P, Ellul J (2009). Acute post-stroke adiponectin in relation to stroke severity, progression and 6 month functional outcome. Neurol Res. Dec 21. (Epub ahead of print)
14. Matsumoto M, Ishikawa S, Kajii E (2008). Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke. 39: 323-328. (Pubitemid 351619450)
15. Maury E, Brichard SM (2010). Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 314: 1-16.
16. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, et al. (2004). Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart. 90:528-533. (Pubitemid 38530170)
17. Nishimura M, Izumiya Y, Higuchi A, Shibata R, Qiu J, Kudo C, et al. (2008). Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation. 117: 216-223.
18. Ogorodnikova AD, Wassertheil-Smoller S, Mancuso P, Sowers MR, Rajpathak SN, Allison MA, et al. (2010). High-molecularweight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study. Stroke. 41: 1376-1381.
19. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. (1999). Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 100: 2473-2476. (Pubitemid 30005109)
20. Psilopanagioti A, Papadaki H, Kranioti EF, Alexandrides TK, Varakis JN (2009). Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology. 89: 38-47.
21. Sasaki M, Kawano T, Saito T, Yuzawa M, Saito T, Ikoma A, et al. (2007). Hypoadiponectinemia in patients with cerebral infarction: comparison with other atherosclerotic disorders. Am J Med Sci. 333: 140-144. (Pubitemid 47181612)
22. Sasaki M, Otani T, Kawakami M, Ishikawa SE (2010). Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction. Metabolism. 59: 527-532.
23. Söderberg S, Stegmayr B, Stenlund H, Sjöström LG, Agren A, Johansson L, et al. (2004). Leptin, but not adiponectin, predicts stroke in males. J Intern Med. 256: 128-136. (Pubitemid 38998259)
24. Stott DJ, Welsh P, Rumley A, Robertson M, Ford I, Sattar N, et al. (2009). Adipocytokines and risk of stroke in older people: a nested case-control study. Int J Epidemiol. 38: 253-261.
25. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, et al. (2007). Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 13: 332-339. (Pubitemid 46376688)
26. Yamauchi T, Kadowaki T (2008). Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond). 32 Suppl 7: 513-8.
27. Yatomi K, Miyamoto N, Komine-Kobayashi M, Liu M, Oishi H, Arai H, et al. (2009). Pathophysiological dual action of adiponectin after transient focal ischemia in mouse brain. Brain Res. 1297: 169-176.